Trineumin

DB21769InvestigationalSmall molecule

Trineumin: Overview.

Mechanism: Pharmacologically active on TGF-beta receptor type-1
Curator reviewed
Formula / weight: C₂₂H₂₉N₅O₂ · 395.507 g/mol (avg)
Also known as: 4-(4-(2-(Diethylamino)ethoxy)phenyl)-1-(4-methoxybenzyl)-1H-1,2,3-triazol-5-amine
Code names: PRG-N-01

Resolves to

Compound

Structure

InChIKeyCGZIGMPINMFIFS-UHFFFAOYSA-NSMILESCCN(CC)CCOC1=CC=C(C=C1)C1=C(N)N(CC2=CC=C(OC)C=C2)N=N1

Targets

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Trineumin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.